Evoke Wealth’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-395
Closed -$5K 994
2022
Q3
$5K Hold
395
﹤0.01% 889
2022
Q2
$6K Hold
395
﹤0.01% 864
2022
Q1
$6K Sell
395
-5
-1% -$68 ﹤0.01% 875
2021
Q4
$5K Hold
400
﹤0.01% 906
2021
Q3
$5K Hold
400
﹤0.01% 862
2021
Q2
$7K Hold
400
﹤0.01% 807
2021
Q1
$7K Hold
400
﹤0.01% 775
2020
Q4
$7K Sell
400
-450
-53% -$7.18K ﹤0.01% 647
2020
Q3
$12K Buy
850
+450
+113% +$6.61K ﹤0.01% 536
2020
Q2
$6K Buy
400
+180
+82% +$2.37K ﹤0.01% 639
2020
Q1
$2.4K Sell
220
-77
-26% -$1.42K ﹤0.01% 771
2019
Q4
$6.34K Hold
297
﹤0.01% 860
2019
Q3
$6.82K Buy
+297
New +$6.33K ﹤0.01% 913

Other funds holding SBRA

Evoke Wealth's SBRA Position: Q4 2022 in Review

Evoke Wealth sold out of Sabra Healthcare REIT (SBRA) in Q4 2022, closing a stake of 395 shares — an estimated $5K sold.

Evoke Wealth first reported a position in SBRA in Q3 2019 and held it in 13 quarters. The position peaked at $12K in Q3 2020. 327 funds tracked by Wall St. Rank hold SBRA as of Q4 2022.

  • Evoke Wealth reported no remaining Sabra Healthcare REIT position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 395 Sabra Healthcare REIT shares in Q4 2022, an estimated $5K.
  • Evoke Wealth first reported a position in Sabra Healthcare REIT in Q3 2019 and held it in 13 quarters.
  • Evoke Wealth's Sabra Healthcare REIT position peaked at $12K in Q3 2020.
  • 327 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.